Davies F.E.
65
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 5 |
| Genética | 3 |
| Patología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 5 |
| Fisiología humana | 2 |
| Bioquímica | 2 |
| Anatomía humana, citología, histología | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 5 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Johnson D.C. | 5 |
| Gonzalez D. | 5 |
| Morgan G.J. | 5 |
| Paola E. Leone | 5 |
| Ross F.M. | 5 |
| Walker B.A. | 5 |
| Jenner M.W. | 5 |
| Dickens N.J. | 4 |
| Protheroe R.K.M. | 3 |
| Chiecchio L. | 3 |
Cargando gráfico
Publicaciones del autor
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma
ArticleAbstract: Multiple myeloma is characterized by genomic alterations frequently involving gains and losses of chPalabras claves:Autores:Davies F.E., Gonzalez D., Jenner M.W., Johnson D.C., Li C., Morgan G.J., Paola E. Leone, Ross F.M., Walker B.A.Fuentes:googlescopusHomozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome
ArticleAbstract: Purpose: Myeloma is a clonal malignancy of plasma cells. Poor-prognosis risk is currently identifiedPalabras claves:Autores:Boyd K.D., Brito J.L., Davies F.E., Dickens N.J., Gonzalez D., Gregory W.M., Jenner M.W., Johnson D.C., Morgan G.J., Paola E. Leone, Ross F.M., Walker B.A., Zeisig A.Fuentes:googlescopusDeletions of CDKN2C in multiple myeloma: Biological and clinical implications
ArticleAbstract: Purpose: Deletions of chromosome 1 have been described in 7% to 40% of cases of myeloma with inconsiPalabras claves:Autores:Brito J.L., Chen-Kiang S., Chiecchio L., Dagrada G.P., Davies F.E., Dickens N.J., Else M., Gonzalez D., Jenner M.W., Johnson D.C., Morgan G.J., Paola E. Leone, Protheroe R.K.M., Ross F.M., Walker B.A.Fuentes:googlescopusA compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
ArticleAbstract: To obtain a comprehensive genomic profile of presenting multiple myeloma cases we performed high-resPalabras claves:Autores:Boyd K.D., Chiecchio L., Dagrada G.P., Davies F.E., Dickens N.J., Gonzalez D., Gregory W.M., Jenner M.W., Johnson D.C., Konn Z.J., Morgan G.J., Paola E. Leone, Protheroe R.K.M., Ross F.M., Stockley D.M., Walker B.A.Fuentes:googlescopusGene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma
ArticleAbstract: We performed fluorescent in situ hybridization (FISH) for 16q23 abnormalities in 861 patients with nPalabras claves:Autores:Cabanas E.D., Chiecchio L., Cross N.C.P., Dagrada G.P., Davies F.E., Dickens N.J., Else M., Gonzalez D., Jenner M.W., Johnson D.C., Morgan G.J., Nightingale M., Paola E. Leone, Protheroe R.K.M., Ross F.M., Stockley D.M., Walker B.A.Fuentes:googlescopus